• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《中国中医药信息杂志》 >加味当归贝母苦参丸对MFC胃癌荷瘤小鼠瘤组织Toll样受体通路分子的影响

加味当归贝母苦参丸对MFC胃癌荷瘤小鼠瘤组织Toll样受体通路分子的影响

         
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective To study the effects of modified Danggui Beimu Kushen Pills on the expressions of TLR2, TLR4, TLR6, TRAF6 and MyD88 in tumor tissues on MFC gastric cancer bearing mice; To discuss relevant mechanism of action. Methods MFC gastric cancer bearing mice were employed to perform anti-tumor experiment in vivo in this study. A total of eligible 48 mice were randomly divided into model group, DDP positive control group, modified Danggui Beimu Kushen Pills high-dose and low-dose groups, modified Danggui Beimu Kushen Pills high-dose and low-dose combined with DDP groups. The treatment was conducted once a day, and lasted for 14 continuous days. After the last administration of gavage orally treatment, all mice were anaesthetized and killed by cervical dislocation method to obtain tumor tissue completely for further HE staining measure and detection of TLR2, TLR4, TLR6, TRAF6 and MyD88 in tumor tissue with the method of RT-qPCR and immunohistochemistry. Meanwhile, the tumor growth was observed and the general conditions of mice were recorded. Results The model group was rich in tumor cells; the sizes of cells were different; the volume was large; the nucleus was deeply stained and the heterotypic shape was obvious, and the small focal necrosis was seen. The number of tumor cells in each administration group was reduced; the arrangement was loose; the cell volume was significantly reduced, and the nuclear pyknosis was reduced. Cell necrosis significantly increased; the number of interstitial blood vessels decreased; collagen fibers increased, especially in modified Danggui Beimu Kushen Pills high-dose and low-dose combined with DDP groups. Compared with the model group, the expressions of TLR2, TLR4, TLR6, TRAF6 and MyD88 mRNA and protein decreased in each administration group. TLR2, TLR4, TLR6, TRAF6 and MyD88 were lighter and weakly positive expressed in modified Danggui Beimu Kushen Pillshigh-dose and low-dose combined with DDP groups, the protein changes were more obvious Compared with DDP positive control group, modified Danggui Beimu Kushen Pills high-dose and low-dose groups. Conclusion Modified Danggui Beimu Kushen Pills can down-regulate TLR2, TLR4, TLR6, TRAF6 and MyD88 expression of tumor tissue in MFC gastric cancer bearing mice at both mRNA and protein levels to play anti-tumor pharmacology action.%目的 观察加味当归贝母苦参丸对MFC胃癌荷瘤小鼠瘤组织Toll样受体(TLR2、TLR4、TLR6)、肿瘤坏死因子受体相关因子6(TRAF6)和髓分化因子88(MyD88)表达的影响,探讨其相关的作用机制.方法 建立MFC胃癌荷瘤小鼠模型进行体内抗肿瘤试验.将筛选合格的48只MFC胃癌荷瘤小鼠随机分为模型组,阳性对照组(顺铂组),加味当归贝母苦参丸高剂量组(当高组)、低剂量组(当低组)和顺铂联合加味当归贝母苦参丸高剂量组(顺高组)、低剂量组(顺低组),各给药组给予相应药物灌胃,连续14 d,观察肿瘤生长情况及小鼠一般情况、肿瘤大体标本及HE染色后组织形态;RT-qPCR和免疫组化分别检测肿瘤组织TLR2、TLR4、TLR6、TRAF6和MyD88的表达.结果 模型组肿瘤细胞丰富,细胞大小不一、体积大、核大深染、异型明显,可见小灶性坏死,间质血管丰富;各给药组肿瘤细胞数量减少、排列疏松、细胞体积明显缩小、核固缩,细胞坏死明显增加,间质血管数量减少,胶原纤维增多,其中以顺低组、顺高组较为明显.与模型组比较,各给药组TLR2、TLR4、TLR6、TRAF6和MyD88 mRNA和蛋白表达均降低,顺低组、顺高组TLR2、TLR4、TLR6、TRAF6和MyD88蛋白着色变浅,呈弱阳性表达,较顺铂组、当高组、当低组蛋白改变更加明显.结论 加味当归贝母苦参丸可能通过下调荷瘤小鼠肿瘤组织TLR2、TLR4、TLR6、TRAF6和MyD88 mRNA和蛋白的表达,发挥抗肿瘤作用.

著录项

  • 来源
    《中国中医药信息杂志》 |2017年第8期|54-59|共6页
  • 作者

    李海龙; 王勇; 翟宇; 程小丽; 安霞; 李红亮; 康万荣; 吴红彦;

  • 作者单位

    甘肃中医药大学临床医学院,甘肃 兰州 730000;

    甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药药理与毒理学重点实验室,甘肃 兰州 730000;

    甘肃中医药大学临床医学院,甘肃 兰州 730000;

    甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药药理与毒理学重点实验室,甘肃 兰州 730000;

    甘肃中医药大学临床医学院,甘肃 兰州 730000;

    甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药药理与毒理学重点实验室,甘肃 兰州 730000;

    甘肃中医药大学教学实验中心,甘肃 兰州 730000;

    甘肃中医药大学附属医院,甘肃 兰州 730020;

    甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药药理与毒理学重点实验室,甘肃 兰州 730000;

    甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药药理与毒理学重点实验室,甘肃 兰州 730000;

    甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药药理与毒理学重点实验室,甘肃 兰州 730000;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 中药实验药理;
  • 关键词

    加味当归贝母苦参丸; 胃癌; Toll样受体通路; 小鼠;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号